Myotonic dystrophy type 1 (DM1)-specific induced pluripotent stem cells (iPS): an innovative platform for myogenic and cardiomyogenic differentiation and validation of novel therapeutic approaches

Medicine & Life Sciences

1. Myotonic Dystrophy 100%
2. Poisons 76%
3. Genes 31%
4. Pluripotent Stem Cells 30%
5. Induced Pluripotent Stem Cells 29%
6. Cardiac Myocytes 24%
7. Inborn Genetic Diseases 23%
8. Skeletal Muscle 20%
9. Heart 16%
10. Therapeutics 12%